News

D Molecular Therapeutics (NASDAQ:FDMT) achieves FDA RMAT status for 4D-150 as a diabetic macular edema treatment, backed by ...
An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...
Look out for the key nutrients. When in doubt, try to prioritize foods with fiber and complex carbs, protein, and healthy ...
From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Before you make your next sandwich, be sure to check your freezer or your breadbox. The U.S. Food and Drug Administration (FDA) announced yet another food recall, this time for various bread products ...
With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...
Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...
From sweet treats to cold medicine, Red Dye No. 3 has been a popular food additive ingredient for decades. Now, it's under scrutiny.
A recall of seafood burgers by the Connecticut based company Caraluzzi's Markets has been issued a Class I risk ...
Johnson & Johnson ’s anti-FcRn antibody nipocalimab has been approved by the FDA to treat generalized myasthenia gravis. The drug will be marketed under the brand name Imaavy.
The FDA has lost several senior employees in recent weeks, including some who have been at the agency for more than two ...